These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2141793)

  • 1. Glycosylation at Asn-184 inhibits the conversion of single-chain to two-chain tissue-type plasminogen activator by plasmin.
    Wittwer AJ; Howard SC
    Biochemistry; 1990 May; 29(17):4175-80. PubMed ID: 2141793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kringle glycosylation in a modified human tissue plasminogen activator improves functional properties.
    Berg DT; Burck PJ; Berg DH; Grinnell BW
    Blood; 1993 Mar; 81(5):1312-22. PubMed ID: 8382971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural determinants of the noncatalytic chain of tissue-type plasminogen activator that modulate its association rate with plasminogen activator inhibitor-1.
    de Serrano VS; Castellino FJ
    J Biol Chem; 1990 Jun; 265(18):10473-8. PubMed ID: 2113057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual effect of synthetic plasmin substrates on plasminogen activation.
    Kolev K; Owen WG; Machovich R
    Biochim Biophys Acta; 1995 Mar; 1247(2):239-45. PubMed ID: 7696314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of polymerised fibrin on the catalytic activities of one-chain tissue-type plasminogen activator as revealed by an analogue resistant to plasmin cleavage.
    Petersen LC; Johannessen M; Foster D; Kumar A; Mulvihill E
    Biochim Biophys Acta; 1988 Feb; 952(3):245-54. PubMed ID: 2962643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activation of type 1 and type 2 plasminogen by type I and type II tissue plasminogen activator.
    Mori K; Dwek RA; Downing AK; Opdenakker G; Rudd PM
    J Biol Chem; 1995 Feb; 270(7):3261-7. PubMed ID: 7852411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of N-glycosylation on in vitro activity of Bowes melanoma and human colon fibroblast derived tissue plasminogen activator.
    Wittwer AJ; Howard SC; Carr LS; Harakas NK; Feder J; Parekh RB; Rudd PM; Dwek RA; Rademacher TW
    Biochemistry; 1989 Sep; 28(19):7662-9. PubMed ID: 2514792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities.
    Husain SS
    Biochemistry; 1991 Jun; 30(23):5797-805. PubMed ID: 1828371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of an enzyme converting single-chain tissue-type plasminogen activator to the two-chain form in preovulatory human follicular fluid.
    Ohnishi J; Yokota J; Rajapakse RG; Ohnishi E; Kudo T; Wada S; Takahashi T
    Mol Reprod Dev; 2004 Feb; 67(2):178-85. PubMed ID: 14694433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformations of tissue plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDAR.
    Bertrand T; Lesept F; Chevilley A; Lenoir S; Aimable M; Briens A; Hommet Y; Bardou I; Parcq J; Vivien D
    Cell Death Dis; 2015 Oct; 6(10):e1924. PubMed ID: 26469972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of tissue plasminogen activator-plasmin system in depolarization-evoked dopamine release in the nucleus accumbens of mice.
    Ito M; Nagai T; Kamei H; Nakamichi N; Nabeshima T; Takuma K; Yamada K
    Mol Pharmacol; 2006 Nov; 70(5):1720-5. PubMed ID: 16908600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
    Lobov S; Croucher DR; Saunders DN; Ranson M
    Thromb Haemost; 2008 Aug; 100(2):319-29. PubMed ID: 18690354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
    Rydzewski A; Castellino FJ
    Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trinitrobenzoylated poly(D-lysine) as a stimulator of interactions between plasminogen, plasmin, and tissue-type plasminogen activator.
    Petersen LC; Suenson E
    Biochim Biophys Acta; 1986 Sep; 883(2):313-25. PubMed ID: 2943320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of tissue plasminogen activator to human aortic endothelial cells.
    Sanzo MA; Howard SC; Wittwer AJ; Cochrane HM
    Biochem J; 1990 Jul; 269(2):475-82. PubMed ID: 2117440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
    Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
    Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial orientation of tissue-type plasminogen activator bound at the melanoma cell surface.
    Bizik J; Trancikova D; Felnerova D; Verheijen JH; Vaheri A
    Biochem Biophys Res Commun; 1997 Oct; 239(1):322-8. PubMed ID: 9345318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical properties of recombinant mutants of nonglycosylated single chain urokinase-type plasminogen activator.
    Li XK; Lijnen HR; Nelles L; Hu MH; Collen D
    Biochim Biophys Acta; 1992 Sep; 1159(1):37-43. PubMed ID: 1390910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.